DOI QR코드

DOI QR Code

Systemic effects of fluoroscopically guided epidural steroid injection with dexamethasone

  • Kang, Woo Young (Department of Radiology, Seoul National University Bundang Hospital) ;
  • Lee, Joon Woo (Department of Radiology, Seoul National University Bundang Hospital) ;
  • Lee, Eugene (Department of Radiology, Seoul National University Bundang Hospital) ;
  • Kang, Yusuhn (Department of Radiology, Seoul National University Bundang Hospital) ;
  • Ahn, Joong Mo (Department of Radiology, Seoul National University Bundang Hospital) ;
  • Kang, Heung Sik (Department of Radiology, Seoul National University Bundang Hospital)
  • Received : 2019.05.08
  • Accepted : 2019.06.17
  • Published : 2019.07.01

Abstract

Background: Epidural steroid injections (ESIs) have been widely used in managing spinal pain. Dexamethasone has recently emerged as a useful drug in this setting, relative to particulate steroids, although the associated systemic effects have not been fully elucidated. This study aimed to investigate the incidences and types of systemic effects after fluoroscopically guided ESI with dexamethasone. Methods: This retrospective study included 888 ESIs with dexamethasone (fluoroscopically guided at the cervical and lumbosacral levels) performed on 825 patients during January to June 2017. Data regarding systemic effects were collected via telephone interviews using a standardized questionnaire at 2 weeks after the procedure. Data on patient demographic, clinical, and procedural characteristics were collected and analyzed to identify factors that were associated with systemic effects. All statistical analyses were performed using the chi-squared test. Results: Among the 825 patients, 40 patients (4.8%) experienced systemic effects during the 2-week follow-up period. The most common systemic effect was facial flushing (12 patients, 1.5%), which was followed by urticaria (7 patients, 0.8%) and insomnia (7 patients, 0.8%). A history of spine surgery was significantly associated with the occurrence of systemic effects (P = 0.036). Systemic effects were significantly more common for injections at the cervical level than at the lumbar level (P = 0.019). Conclusions: Approximately 4.8% of the patients who underwent ESI with dexamethasone experienced minor and transient systemic effects. These effects were more common in patients who had undergone a previous spine surgery or received a cervical ESI.

Keywords

References

  1. Manchikanti L, Pampati V, Falco FJ, Hirsch JA. Assessment of the growth of epidural injections in the medicare population from 2000 to 2011. Pain Physician 2013; 16: E349-64. https://doi.org/10.36076/ppj.2013/16/E349
  2. McLain RF, Kapural L, Mekhail NA. Epidural steroid therapy for back and leg pain: mechanisms of action and efficacy. Spine J 2005; 5: 191-201. https://doi.org/10.1016/j.spinee.2004.10.046
  3. Saal JS, Franson RC, Dobrow R, Saal JA, White AH, Goldthwaite N. High levels of inflammatory phospholipase A2 activity in lumbar disc herniations. Spine (Phila Pa 1976) 1990; 15: 674-8. https://doi.org/10.1097/00007632-199007000-00011
  4. Bensler S, Sutter R, Pfirrmann CW, Peterson CK. Long term outcomes from CT-guided indirect cervical nerve root blocks and their relationship to the MRI findings--a prospective Study. Eur Radiol 2015; 25: 3405-13. https://doi.org/10.1007/s00330-015-3758-4
  5. Watts RW, Silagy CA. A meta-analysis on the efficacy of epidural corticosteroids in the treatment of sciatica. Anaesth Intensive Care 1995; 23: 564-9. https://doi.org/10.1177/0310057X9502300506
  6. Epstein NE. The risks of epidural and transforaminal steroid injections in the spine: commentary and a comprehensive review of the literature. Surg Neurol Int 2013; 4(Suppl 2): S74-93.
  7. Botwin KP, Baskin M, Rao S. Adverse effects of fluoroscopically guided interlaminar thoracic epidural steroid injections. Am J Phys Med Rehabil 2006; 85: 14-23. https://doi.org/10.1097/01.phm.0000184475.44853.82
  8. Botwin KP, Castellanos R, Rao S, Hanna AF, Torres-Ramos FM, Gruber RD, et al. Complications of fluoroscopically guided interlaminar cervical epidural injections. Arch Phys Med Rehabil 2003; 84: 627-33. https://doi.org/10.1016/S0003-9993(03)04862-1
  9. Botwin KP, Gruber RD, Bouchlas CG, Torres-Ramos FM, Freeman TL, Slaten WK. Complications of fluoroscopically guided transforaminal lumbar epidural injections. Arch Phys Med Rehabil 2000; 81: 1045-50. https://doi.org/10.1053/apmr.2000.7166
  10. Derby R, Lee SH, Kim BJ, Chen Y, Seo KS. Complications following cervical epidural steroid injections by expert interventionalists in 2003. Pain Physician 2004; 7: 445-9.
  11. Huston CW, Slipman CW, Garvin C. Complications and side effects of cervical and lumbosacral selective nerve root injections. Arch Phys Med Rehabil 2005; 86: 277-83. https://doi.org/10.1016/j.apmr.2004.02.018
  12. Pobiel RS, Schellhas KP, Eklund JA, Golden MJ, Johnson BA, Chopra S, et al. Selective cervical nerve root blockade: prospective study of immediate and longer term complications. AJNR Am J Neuroradiol 2009; 30: 507-11. https://doi.org/10.3174/ajnr.A1415
  13. Karaman H, Kavak GO, Tufek A, Yldrm ZB. The complications of transforaminal lumbar epidural steroid injections. Spine (Phila Pa 1976) 2011; 36: E819-24. https://doi.org/10.1097/BRS.0b013e3181f32bae
  14. Plastaras C, McCormick ZL, Garvan C, Macron D, Joshi A, Chimes G , et al. Adverse events associated with fluoroscopically guided lumbosacral transforaminal epidural steroid injections. Spine J 2015; 15: 2157-65. https://doi.org/10.1016/j.spinee.2015.05.034
  15. McGrath JM, Schaefer MP, Malkamaki DM. Incidence and characteristics of complications from epidural steroid injections. Pain Med 2011; 12: 726-31. https://doi.org/10.1111/j.1526-4637.2011.01077.x
  16. Manchikanti L, Malla Y, Wargo BW, Cash KA, Pampati V, Fellows B. A prospective evaluation of complications of 10,000 fluoroscopically directed epidural injections. Pain Physician 2012; 15: 131-40.
  17. El Abd O, Amadera J, Pimentel DC, Gomba L. Immediate and acute adverse effects following transforaminal epidural steroid injections with dexamethasone. Pain Physician 2015; 18: 277-86.
  18. Watkins TW, Dupre S, Coucher JR. Ropivacaine and dexamethasone: a potentially dangerous combination for therapeutic pain injections. J Med Imaging Radiat Oncol 2015; 59: 571-7. https://doi.org/10.1111/1754-9485.12333
  19. Lee GY, Lee JW, Yeom JS, Kim KJ, Shin HI, Kang HS. The incidence of various types of systemic reactions related to epidural steroid injections: a prospective observational study. Korean J Radiol 2018; 19: 301-10. https://doi.org/10.3348/kjr.2018.19.2.301
  20. Palmer WE. Spinal injections for pain management. Radiology 2016; 281: 669-88. https://doi.org/10.1148/radiol.2016152055
  21. MacMahon PJ, Huang AJ, Palmer WE. Spine injectables: what is the safest cocktail? Am J Roentgenol 2016; 207: 526-33. https://doi.org/10.2214/AJR.16.16379
  22. Schneider B, Zheng P, Mattie R, Kennedy DJ. Safety of epidural steroid injections. Expert Opin Drug Saf 2016; 15: 1031-9. https://doi.org/10.1080/14740338.2016.1184246
  23. Goodman BS, Posecion LW, Mallempati S, Bayazitoglu M. Complications and pitfalls of lumbar interlaminar and transforaminal epidural injections. Curr Rev Musculoskelet Med 2008; 1: 212-22. https://doi.org/10.1007/s12178-008-9035-2
  24. Derby R, Lee SH, Date ES, Lee JH, Lee CH. Size and aggregation of corticosteroids used for epidural injections. Pain Med 2008; 9: 227-34. https://doi.org/10.1111/j.1526-4637.2007.00341.x
  25. MacMahon PJ, Eustace SJ, Kavanagh EC. Injectable corticosteroid and local anesthetic preparations: a review for radiologists. Radiology 2009; 252: 647-61. https://doi.org/10.1148/radiol.2523081929
  26. Wright JM, Cowper JJ, Page Thomas DP, Knight CG. The hydrolysis of cortisol 21-esters by a homogenate of inflamed rabbit synovium and by rheumatoid synovial fluid. Clin Exp Rheumatol 1983; 1: 137-41.
  27. Dreyfuss P, Baker R, Bogduk N. Comparative effectiveness of cervical transforaminal injections with particulate and nonparticulate corticosteroid preparations for cervical radicular pain. Pain Med 2006; 7: 237-42. https://doi.org/10.1111/j.1526-4637.2006.00162.x
  28. Friedly JL, Comstock BA, Heagerty PJ, Bauer Z, Rothman MS, Suri P, et al. Systemic effects of epidural steroid injections for spinal stenosis. Pain 2018; 159: 876-83. https://doi.org/10.1097/j.pain.0000000000001158
  29. Gala FB, Aswani Y. Imaging in spinal posterior epidural space lesions: a pictorial essay. Indian J Radiol Imaging 2016; 26: 299-315. https://doi.org/10.4103/0971-3026.190406
  30. Ahadian FM, McGreevy K, Schulteis G. Lumbar transforaminal epidural dexamethasone: a prospective, randomized, doubleblind, dose-response trial. Reg Anesth Pain Med 2011; 36: 572-8. https://doi.org/10.1097/AAP.0b013e318232e843
  31. Everett CR, Baskin MN, Speech D, Novoseletsky D, Patel R. Flushing as a side effect following lumbart ransforaminal epidural steroid injection. Pain Physician 2004; 7: 427-9.

Cited by

  1. Usefulness of the Inferior Articular Process’s Cross-Sectional Area as a Morphological Parameter for Predicting Central Lumbar Spinal Stenosis vol.9, pp.1, 2020, https://doi.org/10.3390/jcm9010214
  2. Safety of epidural steroids: a review vol.16, pp.1, 2021, https://doi.org/10.17085/apm.21002
  3. The COVID‐19 vaccine and interventional procedures: Exploring the relationship between steroid administration and subsequent vaccine efficacy vol.21, pp.8, 2019, https://doi.org/10.1111/papr.13062
  4. Steroid injections in pain management: influence on coronavirus disease 2019 vaccines vol.35, pp.1, 2019, https://doi.org/10.3344/kjp.2022.35.1.14